PHARMACOKINETICS OF UPADACITINIB IN PEDIATRIC PATIENTS WITH POLYARTICULAR COURSE JUVENILE IDIOPATHIC ARTHRITIS

被引：2
作者：
Qian, Y. [1 ]
Shmagel, A. [2 ]
Hao, S. [3 ]
Horneff, G. [4 ,5 ]
Brunner, H. [6 ]
Camp, H. [2 ]
Liu, W. [1 ]
Mohamed, M. E. [1 ]
机构：
[1] AbbVie Inc, Clin Pharmacol, N Chicago, IL USA
[2] AbbVie Inc, Immunol Dev, N Chicago, IL USA
[3] AbbVie Inc, Discovery & Exploratory Stat, N Chicago, IL USA
[4] Asklepios Clin Sankt Augustin, Dept Gen Paediat, St Augustin, Germany
[5] Univ Hosp Cologne, Dept Pediat & Adolescents Med, Cologne, Germany
[6] Cincinnati Childrens Hosp Med Ctr, Pediat Rheumatol Collaborat Study Grp PRCSG, Cincinnati, OH USA
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2023年 / 82卷
关键词：
Targeted synthetic drugs; Clinical trials; Disease-modifying drugs; (DMARDs);
D O I：
10.1136/annrheumdis-2023-eular.3883
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
POS0751
引用
收藏
页码：666 / 667
页数：2
相关论文
共 50 条
  • [31] Safety of the COVID-19 vaccination in children with juvenile idiopathic arthritis-A observational study from two pediatric rheumatology centres in Poland
    Opoka-Winiarska, Violetta
    Lipinska, Joanna
    Michalak, Arkadiusz
    Burzynski, Jacek
    Kadziolka, Olga
    Smolewska, Elzbieta
    FRONTIERS IN PEDIATRICS, 2023, 11
  • [32] Association between drug intake and incidence of malignancies in patients with Juvenile Idiopathic Arthritis: a nested case-control study
    Barth, Swaantje
    Schlichtiger, Jenny
    Bisdorff, Betty
    Huegle, Boris
    Michels, Hartmut
    Radon, Katja
    Haas, Johannes-Peter
    PEDIATRIC RHEUMATOLOGY, 2016, 14
  • [33] EFFICACY OF UPADACITINIB IN RHEUMATOID ARTHRITIS PATIENTS WITH INADEQUATE RESPONSE TO FIRST GENERATION JAK INHIBITORS
    Kamiya, M.
    Mori, S.
    Yamazaki, K.
    Togawa, D.
    ANNALS OF THE RHEUMATIC DISEASES, 2024, 83
  • [34] Safety and effectiveness of abatacept in juvenile idiopathic arthritis: results from the PRINTO/PRCSG registry
    Lovell, Daniel J.
    Tzaribachev, Nikolay
    Henrickson, Michael
    Simonini, Gabriele
    Griffin, Thomas A.
    Alexeeva, Ekaterina
    Bohnsack, John F.
    Zeft, Andrew
    Horneff, Gerd
    Vehe, Richard K.
    Stanevica, Valda
    Tarvin, Stacey
    Trachana, Maria
    del Rio, Ana Quintero
    Huber, Adam M.
    Kietz, Daniel
    Orban, Ilonka
    Dare, Jason
    Foeldvari, Ivan
    Quartier, Pierre
    Dominique, Alyssa
    Simon, Teresa A.
    Martini, Alberto
    Brunner, Hermine, I
    Ruperto, Nicolino
    RHEUMATOLOGY, 2024, : SI195 - SI206
  • [35] Is tocilizumab a good therapeutic option for RA and systemic-onset juvenile idiopathic arthritis?
    Gabay, Cem
    NATURE CLINICAL PRACTICE RHEUMATOLOGY, 2008, 4 (11): : 572 - 573
  • [36] British Isles Survey of Methotrexate Monitoring Practice During Treatment of Juvenile Idiopathic Arthritis
    Hawley, Daniel P.
    Camina, Nikki
    Rangaraj, Satyapal
    SEMINARS IN ARTHRITIS AND RHEUMATISM, 2011, 40 (04) : 358 - 364
  • [37] Dosing regimen determination for juvenile idiopathic arthritis: A review of studies during drug development
    Ji, Ping
    Chowdhury, Badrul A.
    Yim, Sarah
    Sahajwalla, Chandrahas G.
    JOURNAL OF PHARMACEUTICAL SCIENCES, 2012, 101 (08) : 2621 - 2634
  • [38] Changes in Treatments and Outcomes After Implementation of a National Universal Access Program for Juvenile Idiopathic Arthritis
    Concha, Sara
    Morales, Pamela S.
    Talesnik, Eduardo
    Borzutzky, Arturo
    JOURNAL OF RHEUMATOLOGY, 2021, 48 (11) : 1725 - 1731
  • [39] EFFICACY AND SAFETY OF SECUKINUMAB IN JUVENILE IDIOPATHIC ARTHRITIS: INTERIM RESULTS FROM THE EXTENSION OF THE JUNIPERA TRIAL
    Ruperto, N.
    Foeldvari, I.
    Alexeeva, E.
    Ayaz, N. Aktay
    Schulert, G.
    Ozen, S.
    Popov, A.
    Ramanan, A.
    Scott, C.
    Sozeri, B.
    Zholobova, E.
    Chakraborty, S.
    Zhu, X.
    Martin, R.
    Whelan, S.
    Kaur, S.
    Pricop, L.
    Lovell, D. J.
    Martini, A.
    Brunner, H.
    ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 : 379 - 380
  • [40] Relative efficacy and safety of tofacitinib, baricitinib, upadacitinib, and filgotinib in comparison to adalimumab in patients with active rheumatoid arthritis
    Lee, Young Ho
    Song, Gwan Gyu
    ZEITSCHRIFT FUR RHEUMATOLOGIE, 2020, 79 (08): : 785 - 796
12345